600380 健康元
已收盘 09-18 15:00:00
资讯
新帖
简况
健康元09月13日主力资金流入1231万元 连续5日加仓
市场透视 · 09-13
健康元09月13日主力资金流入1231万元 连续5日加仓
健康元(600380.SH)拟出售部分不动产 涉及2018年配股的募投项目珠海大健康产业基地
智通财经 · 09-10
健康元(600380.SH)拟出售部分不动产 涉及2018年配股的募投项目珠海大健康产业基地
健康元最新公告:全资子公司拟转让土地使用权及其地面建筑物
证券之星 · 09-10
健康元最新公告:全资子公司拟转让土地使用权及其地面建筑物
健康元(600380.SH):子公司健康中国拟转让土地使用权及其地面建筑物
格隆汇资讯 · 09-10
健康元(600380.SH):子公司健康中国拟转让土地使用权及其地面建筑物
健康元:9月6日接受机构调研,国投证券、长盛基金参与
证券之星 · 09-09
健康元:9月6日接受机构调研,国投证券、长盛基金参与
【调研快报】健康元接待华源证券等多家机构调研
东方财富 · 09-09
【调研快报】健康元接待华源证券等多家机构调研
健康元09月06日遭主力抛售224万元 环比增加761.54%
市场透视 · 09-06
健康元09月06日遭主力抛售224万元 环比增加761.54%
华安证券:给予健康元增持评级
证券之星 · 09-06
华安证券:给予健康元增持评级
健康元业绩再双降营销费达16.4亿 货币资金152亿近四年分红率低于30%
长江商报 · 09-05
健康元业绩再双降营销费达16.4亿 货币资金152亿近四年分红率低于30%
健康元(600380.SH)拟斥资3亿元至5亿元回购股份
智通财经 · 09-02
健康元(600380.SH)拟斥资3亿元至5亿元回购股份
健康元:拟以3亿元-5亿元回购公司股份
澎湃新闻 · 09-02
健康元:拟以3亿元-5亿元回购公司股份
健康元最新公告:拟以3亿元至5亿元回购公司股份
证券之星 · 09-02
健康元最新公告:拟以3亿元至5亿元回购公司股份
健康元:拟3亿至5亿元回购股份用于减资
美港电讯 · 09-02
健康元:拟3亿至5亿元回购股份用于减资
健康元: 镇痛新药FZ008-145正在开展Ⅰ期临床研究
证券之星 · 08-30
健康元: 镇痛新药FZ008-145正在开展Ⅰ期临床研究
【私募调研记录】大朴资产调研健康元、兴齐眼药等5只个股(附名单)
证券之星 · 08-30
【私募调研记录】大朴资产调研健康元、兴齐眼药等5只个股(附名单)
【私募调研记录】景林资产调研新宝股份、健康元等6只个股(附名单)
证券之星 · 08-30
【私募调研记录】景林资产调研新宝股份、健康元等6只个股(附名单)
健康元:8月26日接受机构调研,包括知名机构景林资产,淡水泉,趣时资产的多家机构参与
证券之星 · 08-29
健康元:8月26日接受机构调研,包括知名机构景林资产,淡水泉,趣时资产的多家机构参与
健康元(600380.SH)实控人提议公司斥3亿元至5亿元回购股份
智通财经 · 08-26
健康元(600380.SH)实控人提议公司斥3亿元至5亿元回购股份
健康元最新公告:实际控制人、董事长提议以3亿元-5亿元回购公司股份
证券之星 · 08-26
健康元最新公告:实际控制人、董事长提议以3亿元-5亿元回购公司股份
健康元(600380.SH):董事长提议回购公司股份
格隆汇资讯 · 08-26
健康元(600380.SH):董事长提议回购公司股份
加载更多
公司概况
公司名称:
健康元药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2001-06-08
主营业务:
健康元药业集团股份有限公司主营业务是从事医药产品及保健品研发、生产及销售。公司的主要产品有化学制剂、化学原料药及中间体、中药制剂、诊断试剂及设备、生物制品和保健食品等。公司成立二十多年来,一直专注于医药、保健品领域的经营,其优良的产品质量及市场服务等树立了公司长久以来成功的品牌形象,并为公司赢得了广泛的市场认可。公司保健品“太太”、“静心”、“鹰牌”,处方药“倍能”、“速能”及丽珠集团旗下系列产品的众多品牌,为公司赢得了广泛知名度和品牌优势。
发行价格:
24.80
{"stockData":{"symbol":"600380","market":"SH","secType":"STK","nameCN":"健康元","latestPrice":9.54,"timestamp":1726642800000,"preClose":9.53,"halted":0,"volume":7667781,"delay":0,"floatShares":1873999999,"shares":1873999999,"eps":0.749,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"09-18 15:00:00","open":9.5,"high":9.61,"low":9.4,"amount":72818200,"amplitude":0.022,"askPrice":9.54,"askSize":45,"bidPrice":9.53,"bidSize":261,"shortable":0,"etf":0,"ttmEps":0.749,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726709400000},"adr":0,"adjPreClose":9.53,"symbolType":"stock","openAndCloseTimeList":[[1726623000000,1726630200000],[1726635600000,1726642800000]],"highLimit":10.48,"lowLimit":8.58,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1874200420,"pbRate":1.25,"roa":"--","roe":"5.5%","epsLYR":0.758,"committee":-0.296099,"marketValue":17880000000,"floatMarketCap":17880000000,"peRate":12.736982,"changeRate":0.001,"turnoverRate":0.0041,"status":0,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-09-19。"},"requestUrl":"/m/hq/s/600380","defaultTab":"news","newsList":[{"id":"2467166757","title":"健康元09月13日主力资金流入1231万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2467166757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467166757?lang=zh_cn&edition=full","pubTime":"2024-09-13 15:17","pubTimestamp":1726211854,"startTime":"0","endTime":"0","summary":"09月13日, 健康元股价跌1.45%,报收9.53元,成交金额9525万元,换手率0.53%,振幅2.38%,量比1.00。健康元今日主力资金净流入1231万元,连续5日净流入,上一交易日主力净流入597万元,今日环比增加106.20%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为66.67%,平均涨幅为0.31%。该股近5个交易日下跌3.64%,主力资金累计净流入2868万元;近20日主力资金累计净流入2246万元,其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091315210595623b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024091315210595623b28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600380","BK0046","BK0077","BK0239","BK0028","BK0114"],"gpt_icon":0},{"id":"2466353154","title":"健康元(600380.SH)拟出售部分不动产 涉及2018年配股的募投项目珠海大健康产业基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2466353154","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466353154?lang=zh_cn&edition=full","pubTime":"2024-09-10 19:02","pubTimestamp":1725966121,"startTime":"0","endTime":"0","summary":"智通财经APP讯,健康元(600380.SH)公告,公司全资子公司健康药业(中国)有限公司拟将其持有的位于珠海市金湾区三灶镇湖滨路南侧、滨河路东侧,宗地面积为94538㎡的国有建设用地使用权及其地面建筑物以人民币7952.00万元(含税)转让于珠海洋溢生物医药有限公司。据悉,本次交易涉及公司2018年配股的募投项目珠海大健康产业基地建设项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1181576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600380","BK0046","BK0188","BK0028","BK0239","BK0077","BK0114"],"gpt_icon":0},{"id":"2466435502","title":"健康元最新公告:全资子公司拟转让土地使用权及其地面建筑物","url":"https://stock-news.laohu8.com/highlight/detail?id=2466435502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466435502?lang=zh_cn&edition=full","pubTime":"2024-09-10 19:00","pubTimestamp":1725966052,"startTime":"0","endTime":"0","summary":"健康元公告,全资子公司健康药业(中国)有限公司拟将其持有的位于珠海市金湾区三灶镇湖滨路南侧、滨河路东侧,宗地面积为94,538㎡的国有建设用地使用权及其地面建筑物以人民币7,952.00万元(含税)转让给珠海洋溢生物医药有限公司。本次交易涉及公司2018年配股的募投项目珠海大健康产业基地建设项目,不构成关联交易,亦不构成重大资产重组。本次交易已经公司九届董事会三次会议和九届监事会三次会议审议通过,尚需提交公司股东大会审议。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000030729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","600380","BK0077","BK0028","BK0188","BK0239","BK0046"],"gpt_icon":0},{"id":"2466438175","title":"健康元(600380.SH):子公司健康中国拟转让土地使用权及其地面建筑物","url":"https://stock-news.laohu8.com/highlight/detail?id=2466438175","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466438175?lang=zh_cn&edition=full","pubTime":"2024-09-10 18:38","pubTimestamp":1725964683,"startTime":"0","endTime":"0","summary":"格隆汇9月10日丨健康元公布,为提高资金使用效率,进一步优化公司资产,本公司全资子公司健康中国拟将其位于珠海市金湾区三灶镇湖滨路南侧、滨河路东侧,宗地面积为94,538㎡的国有建设用地使用权及其地面建筑物进行转让,转让对价为人民币7,952.00万元(含税),受让方为洋溢生物。本次交易涉及的珠海大健康产业基地建设项目累计使用2018年配股募集资金3,386.29万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240910183808955aab4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240910183808955aab4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","600380","BK0046","BK0077","BK0239","BK0028","BK0114"],"gpt_icon":0},{"id":"2466062169","title":"健康元:9月6日接受机构调研,国投证券、长盛基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2466062169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466062169?lang=zh_cn&edition=full","pubTime":"2024-09-09 19:54","pubTimestamp":1725882880,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年9月9日健康元发布公告称公司于2024年9月6日接受机构调研,国投证券冯俊曦、长盛基金黄施齐 洪靖怡 郝征参与。答:中国慢阻肺患者人数在 1 亿人左右,已成为中国第三大致死性疾病。制剂的销售情况易受到国内医药行业政策变动、市场环境变化等因素影响,未来的销售情况尚存在不确定性。目前该产品也已开通线上购买渠道,京东健康即可购买。健康元主营业务:医药产品及保健品研发、生产及销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900028903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","600380","BK0239","161027","BK0114","BK0028","BK0077"],"gpt_icon":0},{"id":"2466161963","title":"【调研快报】健康元接待华源证券等多家机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2466161963","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466161963?lang=zh_cn&edition=full","pubTime":"2024-09-09 19:47","pubTimestamp":1725882420,"startTime":"0","endTime":"0","summary":"健康元9月9日发布消息,9月4日至9月6日,公司接待华源证券等多家机构调研,接待人员董事长 朱保国,副总裁、董事会秘书 赵凤光,投资总监 朱一帆,董事会办公室主任、证券事务代表 李洪涛,接待地点线上接入、现场调研。答:中国慢阻肺患者人数在1亿人左右,已成为中国第三大致死性疾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-09/doc-incnqkxe1709836.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-09/doc-incnqkxe1709836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","BK0188","600380","BK0046","BK0077","BK0239","BK0028","BK0114"],"gpt_icon":0},{"id":"2465965179","title":"健康元09月06日遭主力抛售224万元 环比增加761.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2465965179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465965179?lang=zh_cn&edition=full","pubTime":"2024-09-06 15:18","pubTimestamp":1725607109,"startTime":"0","endTime":"0","summary":"09月06日, 健康元股价跌1.10%,报收9.89元,成交金额8003万元,换手率0.43%,振幅1.50%,量比0.44。健康元今日主力资金净流出224万元,连续3日净流出,上一交易日主力净流出26万元,今日环比增加761.54%。该股近5个交易日下跌1.20%,主力资金累计净流入359万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1801万元,其中净流出天数为11日。健康元所在的化学制药行业,今日主力净流出2.40亿元,行业排名8/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409061528499ee4d32a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409061528499ee4d32a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0114","BK0239","BK0188","600380","BK0077","BK0046"],"gpt_icon":0},{"id":"2465631593","title":"华安证券:给予健康元增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2465631593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465631593?lang=zh_cn&edition=full","pubTime":"2024-09-06 12:05","pubTimestamp":1725595505,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李昌幸近期对健康元进行研究并发布了研究报告《上半年业绩承压,创新转型与双轮驱动稳步推进》,本报告对健康元给出增持评级,当前股价为9.9元。 处方药稳步推进,原料药与保健品多元发展 上半年健康元处方药板块实现销售收入7.43亿元,同比下降19.49%。抗感染领域收入为1.27亿元,同比增长24.54%。保健食品及OTC板块实现销售收入3.30亿元,同比增长63.74%。维持“增持”投资评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090600016020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","600380"],"gpt_icon":0},{"id":"2465155752","title":"健康元业绩再双降营销费达16.4亿 货币资金152亿近四年分红率低于30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2465155752","media":"长江商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465155752?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:08","pubTimestamp":1725494937,"startTime":"0","endTime":"0","summary":"健康元资金充足,截至今年6月底,其货币资金超过150亿元,而近四年,公司现金分红率均低于30%。营收净利连续四个季度下降健康元出现了营收、净利罕见双降。今年上半年,健康元的销售费用为20.97亿元,同比减少3.02亿元,其中,营销费16.40亿元,同比减少4.37亿元,降幅为21.04%。2020年至2023年,健康元年度盈利均超过10亿元,而其年度现金分红金额分别为2.89亿元、2.78亿元、3.37亿元、3.37亿元,分红率分别为25.76%、20.89%、22.41%、23.38%,均低于证监会要求的“30%”标准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050816059ee0f6b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409050816059ee0f6b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0114","600380","BK0077","BK0028","BK0188","BK0239","BK0046"],"gpt_icon":0},{"id":"2464803098","title":"健康元(600380.SH)拟斥资3亿元至5亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464803098","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464803098?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:51","pubTimestamp":1725274262,"startTime":"0","endTime":"0","summary":"智通财经APP讯,健康元(600380.SH)发布公告,公司拟斥资3亿元至5亿元回购股份,回购价格不超过15.4元/股,回购的股份将用于减少公司注册资本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0114","600380","BK0077","BK0028","BK0188","BK0239","BK0046"],"gpt_icon":0},{"id":"2464083830","title":"健康元:拟以3亿元-5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464083830","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464083830?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:48","pubTimestamp":1725274080,"startTime":"0","endTime":"0","summary":"9月2日晚间,健康元药业集团股份有限公司(健康元,600380.SH)公告,公司拟以3亿元—5亿元回购股份,用于减少公司注册资本,回购股份价格不超过15.4元/股(含)。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-09-02/doc-incmuhue3951064.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-09-02/doc-incmuhue3951064.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0188","600380","BK0239","BK0028","BK0114","BK0077"],"gpt_icon":0},{"id":"2464882480","title":"健康元最新公告:拟以3亿元至5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2464882480","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464882480?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:21","pubTimestamp":1725272476,"startTime":"0","endTime":"0","summary":"健康元公告,公司计划以集中竞价交易方式回购股份,金额不低于3亿元且不超过5亿元,用于减少公司注册资本。回购价格不超过15.40元/股,期限自股东大会审议通过之日起12个月内。公司资金来源为自有资金或自筹资金,预计回购股份占总股本比例1.04%至1.73%。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200025931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","600380","BK0077","BK0239","BK0028","BK0046"],"gpt_icon":0},{"id":"2464026884","title":"健康元:拟3亿至5亿元回购股份用于减资","url":"https://stock-news.laohu8.com/highlight/detail?id=2464026884","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464026884?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:11","pubTimestamp":1725271896,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0046","BK0114","BK0188","BK0077","600380","BK0028","BK0239"],"gpt_icon":0},{"id":"2463586784","title":"健康元:\n镇痛新药FZ008-145正在开展Ⅰ期临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2463586784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463586784?lang=zh_cn&edition=full","pubTime":"2024-08-30 18:08","pubTimestamp":1725012494,"startTime":"0","endTime":"0","summary":"证券之星消息,健康元08月30日在投资者关系平台上答复投资者关心的问题。回购价格上限是根据相关法规,设定为董事会通过回购股份决议前30个交易日公司股票交易均价的150%。具体回购事项目前尚待董事会及股东大会审议,公司将按照相关规定及时履行信息披露义务。投资者:请问镇痛新药FZ008-145有新进展吗健康元董秘:您好!镇痛新药FZ008-145正在开展Ⅰ期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000036444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","BK0046","BK0188","BK0028","BK0239","BK0077","BK0114"],"gpt_icon":0},{"id":"2463915243","title":"【私募调研记录】大朴资产调研健康元、兴齐眼药等5只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2463915243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463915243?lang=zh_cn&edition=full","pubTime":"2024-08-30 08:00","pubTimestamp":1724976057,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月29日披露的机构调研信息,知名私募大朴资产近期对5家上市公司进行了调研,相关名单如下:1)健康元 个股亮点:公司GDR已经于2022-09-26成功上市。团队专注于中国证券市场的投资和研究,并保持主动管理、稳中求进的投资风格。证券之星点评:大朴资产在2021年证券之星私募顶投榜中排名第19位,拥有等知名基金经理。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024083000008664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","600380","BK0239","300573","BK0177","BK0114","BK0028","BK0077"],"gpt_icon":0},{"id":"2463439672","title":"【私募调研记录】景林资产调研新宝股份、健康元等6只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2463439672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463439672?lang=zh_cn&edition=full","pubTime":"2024-08-30 08:00","pubTimestamp":1724976048,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月29日披露的机构调研信息,知名私募景林资产近期对6家上市公司进行了调研,相关名单如下:1)新宝股份 个股亮点:公司研发的部分机器人产品在海外市场已经有销售。这些考虑是上海景林做投资决定和估值过程中的核心。上海景林所管理的基金均给投资人创造了丰厚的长期回报。2008年,景林稳健与景林丰收双双入选晨星中国最佳风险管理的6只基金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2024083000008655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600380","BK0077","BK0028","BK0188","BK0114","BK0046","BK0175","BK0239","002705","BK0224"],"gpt_icon":0},{"id":"2463283779","title":"健康元:8月26日接受机构调研,包括知名机构景林资产,淡水泉,趣时资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2463283779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463283779?lang=zh_cn&edition=full","pubTime":"2024-08-29 16:52","pubTimestamp":1724921566,"startTime":"0","endTime":"0","summary":"化学原料药及中间体实现营业收入 26.44 亿元,同比下降 1.45%。诊断试剂及设备实现营业收入 3.94 亿元,同比增长 32.33%。我们致力于提高产品市场占有率,期待未来该产品为公司贡献新的利润增长。制剂的销售情况易受到国内医药行业政策变动、市场环境变化等因素影响,未来的销售情况尚存在不确定性。在健康元本体,上半年由于多个创新药的引进及多个创新药进入临床阶段,研发费用同比大幅上升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900029710.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0239","BK0188","600380","BK0077","BK0046"],"gpt_icon":0},{"id":"2462526964","title":"健康元(600380.SH)实控人提议公司斥3亿元至5亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2462526964","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462526964?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:57","pubTimestamp":1724666226,"startTime":"0","endTime":"0","summary":"智通财经APP讯,健康元(600380.SH)发布公告,公司实际控制人、董事长朱保国先生提议公司通过上海证券交易所股票交易系统以集中竞价交易方式回购公司人民币普通股(A股)股票,回购资金总额不低于3亿元且不超过5亿元,将全部予以注销减少公司注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1170677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0114","BK0188","600380","BK0077","BK0239","BK0028","BK0046"],"gpt_icon":0},{"id":"2462961808","title":"健康元最新公告:实际控制人、董事长提议以3亿元-5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2462961808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462961808?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:30","pubTimestamp":1724664609,"startTime":"0","endTime":"0","summary":"健康元公告,公司实际控制人、董事长朱保国提议公司通过上海证券交易所股票交易系统以集中竞价交易方式回购公司人民币普通股(A股)股票。回购股份种类为人民币普通股(A股),回购股份方式为通过上海证券交易所股票交易系统以集中竞价交易方式,回购股份用途为全部予以注销减少公司注册资本。回购资金总额不低于人民币3亿元(含)且不超过人民币5亿元(含)。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082600024185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0077","BK0188","BK0028","BK0114","600380"],"gpt_icon":0},{"id":"2462961944","title":"健康元(600380.SH):董事长提议回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2462961944","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462961944?lang=zh_cn&edition=full","pubTime":"2024-08-26 17:24","pubTimestamp":1724664289,"startTime":"0","endTime":"0","summary":"格隆汇8月26日丨健康元(600380.SH)公布,基于对公司未来发展前景的信心、对公司价值的认可,本公司实际控制人、董事长朱保国先生提议公司通过上海证券交易所股票交易系统以集中竞价交易方式回购公司人民币普通股(A股)股票,回购资金总额不低于人民币30,000万元(含)且不超过人民币50,000万元(含)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082617251595c506d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082617251595c506d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0114","600380","BK0028","BK0046","BK0239","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2001-06-08","address":"广东省深圳市南山区高新区北区朗山路17号健康元药业集团大厦","stockEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.088},{"period":"3month","weight":-0.2201},{"period":"6month","weight":-0.1701},{"period":"1year","weight":-0.1736},{"period":"ytd","weight":-0.2201}],"companyName":"健康元药业集团股份有限公司","boardCode":"AI0027","perCapita":"25558股","boardName":"医药制造业","registeredCapital":"187420万元","compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.1083},{"period":"6month","weight":-0.1148},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":-0.091}],"survey":" 健康元药业集团股份有限公司主营业务是从事医药产品及保健品研发、生产及销售。公司的主要产品有化学制剂、化学原料药及中间体、中药制剂、诊断试剂及设备、生物制品和保健食品等。公司成立二十多年来,一直专注于医药、保健品领域的经营,其优良的产品质量及市场服务等树立了公司长久以来成功的品牌形象,并为公司赢得了广泛的市场认可。公司保健品“太太”、“静心”、“鹰牌”,处方药“倍能”、“速能”及丽珠集团旗下系列产品的众多品牌,为公司赢得了广泛知名度和品牌优势。","serverTime":1726646848834,"listedPrice":24.8,"stockholders":"73331人(较上一季度减少6.38%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健康元,600380,健康元股票,健康元股票老虎,健康元股票老虎国际,健康元行情,健康元股票行情,健康元股价,健康元股市,健康元股票价格,健康元股票交易,健康元股票购买,健康元股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健康元(600380)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健康元(600380)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}